Cell Source Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

CLCS Stock

USD 0.98 -0.01 -1.01%

The cycle indicators view organizes Hilbert Transform Dominant Cycle Period indicator and supporting indicators around Cell Source. This view tracks cycle timing and phase shifts in Cell Source price series to support structured performance interpretation without implying advice.

Symbol

Indicator

This analysis covers twenty-nine data points across the selected time horizon. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of Cell Source price series in order to analyze variations of the instantaneous cycles.

Cell Source Technical Analysis Modules

Most technical analysis of Cell Source help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cell from various momentum indicators to cycle indicators. When you analyze Cell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Pink Sheet Overview, Methodology & Data Sources

Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York. Cell Source operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people. A high-level view of Cell Source emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Cell Source has a market cap of 10.61 M.

Methodology

Unless otherwise specified, financial data for Cell Source is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cell (USA Stocks:CLCS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Cell Source may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Last reviewed on February 22nd, 2026

Become your own money manager

Tracking Cell Source inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Insider Screener Now

Insider Screener

Find insiders across different sectors to evaluate their impact on performance

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Momentum Invested few shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Hedge Favorites Invested over 40 shares	Go
	Driverless Cars Invested few shares	Go
	Advertising Invested few shares	Go
	Dividend Beast Invested over 40 shares	Go
	Blockchain Invested few shares	Go
	Investor Favorites Invested over 20 shares	Go
	Cash Cows Invested few shares	Go

Additional Tools for Cell Pink Sheet Analysis

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC